Close

American Vanguard Reports Third Quarter & Nine-Month 2016 Results

November 2, 2016 4:08 PM EDT

Continued Growth Amid Challenging Industry Conditions

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD), today announced financial results for the third quarter and nine-month period ended September 30, 2016.

Fiscal 2016 Third Quarter Financial Highlights – versus Fiscal 2015 Third Quarter Results

• Net sales increased from $72.5 million to $82.5 million

• Net income increased from $2.8 million to $2.9 million

• Earnings per diluted share improved from $0.09 to $0.10

Fiscal 2016 Nine Month Financial Highlights – versus Fiscal 2015 Nine Month Results

• Net sales increased from $205.6 million to $224.6 million

• Net income increased from $3.6 million to $8.9 million

• Earnings per diluted share improved from $0.12 to $0.30

Note: Further details are available in the financial schedules attached to this press release

Eric Wintemute, Chairman and CEO of American Vanguard stated: “Our third quarter and nine month financial results reflect management initiatives to expand our revenue base while maintaining strong operational control. In the face of a variety of Ag Industry headwinds during the quarter, we have remained focused on driving growth in our core products, expanding existing US market share positions and controlling our manufacturing costs while continuing to invest in the future of our business both domestically and internationally. In addition, during the nine month period we have focused on driving our newest products to market both in the US with Scepter, our first Soybean herbicide, and internationally with Nemacur and Bromacil, acquired in early 2015.”

Mr. Wintemute continued: “Third quarter revenues were driven by strong sales of our Metam® soil fumigants, Folex® cotton defoliant and Mocap® and Nemacur® granular insecticides. Quarterly net income improved compared to the prior year but included increased toll manufacturing, and a business mix that included some lower margin products. This had the impact of reducing gross margin compared to net sales, in comparison to the same period of 2015. Through the first nine months of 2016, we are pleased with the 9% revenue growth, the improvement in gross margins from 40% to 41%, and operating expenses which, as a percentage of sales, have decreased from 36% last year to 34.3% this year. Together these factors have generated a 147% increase in net income during the nine month period. Furthermore, we continue to reduce debt, which was $45 million at the end of Q3 2016, as compared to $93 million this time last year.”

Mr. Wintemute concluded: “As we finish calendar year 2016, we are anticipating improved product mix in the final quarter, lower manufacturing output as we manage inventory towards the goal of $125 million and operating expenses at a lower level relative to revenues, as compared to 2015. As we approach the 2017 planting season, we expect to see: modestly improved demand for our industry-leading portfolio of corn products due to reduced distribution channel inventories; incremental expansion of our international footprint; and gradual growth in our overall crop and non-crop businesses. We will continue to improve manufacturing efficiencies, control operating expenses, lower inventory levels and reduce debt. In the face of challenging conditions, American Vanguard continues to demonstrate its capacity to generate growth, sustain profitability, strengthen the balance sheet and enhance stockholder equity.”

Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Wednesday, November 2, 2016. Interested parties may participate in the call by dialing (201)-493-6744 - please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes as well as the S&P Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.amvac-chemical.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in press releases or the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

       
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
 
For the three months

ended September 30

For the nine months

ended September 30

2016   2015 2016   2015
Net sales $ 82,447 $ 72,486 $ 224,645 $ 205,574
Cost of sales   49,461   41,053   132,761   124,370
Gross profit 32,986 31,433 91,884 81,204
Operating expenses   28,255   26,059   77,429   74,325
Operating income 4,731 5,374 14,455 6,879
Interest expense   301   638   1,304   1,941

Income before provision for income taxes and loss on equity investment

4,430 4,736 13,151 4,938
Income tax expense   1,409   1,643   3,672   958
Income before loss on equity investment 3,021 3,093 9,479 3,980
Net loss from equity investment   (180 )   (389 )   (309 )   (580 )
Net income 2,841 2,704 9,170 3,400

Add back net loss (income) attributable to non-controlling interest

  36   68  

(253

)

  204
Net income attributable to American Vanguard $ 2,877 $ 2,772 $ 8,917 $ 3,604
Earnings per common share—basic $ 0.10 $ 0.10 $ 0.31 $ 0.13
Earnings per common share—assuming dilution $ 0.10 $ 0.09 $ 0.30 $ 0.12
Weighted average shares outstanding—basic   28,957   28,753   28,886   28,653
Weighted average shares outstanding—assuming dilution   29,496   29,289   29,385   29,208
 
       
ANALYSIS OF SALES
(In thousands)
For The Three and Nine Months Ended September 30, 2016 and 2015
(Unaudited)
 
Three Months Ended

September 30

Nine Months Ended

September 30

2016   2015 2016   2015
Net sales:
Insecticides $ 25,478 $ 23,539 $ 89,496 $ 85,484
Herbicides/soil fumigants/fungicides 34,242 32,682 80,009 71,973
Other, including plant growth regulators   13,328   7,420   23,148   23,497
Crop 73,048 63,641 192,653 180,954
Non-crop   9,399   8,845   31,992   24,620
Total net sales $ 82,447 $ 72,486 $ 224,645 $ 205,574
Net sales:
US $ 60,033 $ 53,167 $ 161,661 $ 146,231
International   22,414   19,319   62,984   59,343
Total net sales $ 82,447 $ 72,486 $ 224,645 $ 205,574
 
       
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
ASSETS
 
Sept. 30,

2016

Dec. 31,

2015

Current assets:
Cash and cash equivalents $ 6,594 $ 5,524
Receivables:
Trade, net of allowance for doubtful accounts of $159 and $423, respectively 91,091 72,835
Other   3,500   2,554
Total receivables 94,591 75,389
Inventories 141,678 136,477
Prepaid expenses 12,270 11,172
Income taxes receivable 168
Deferred income tax assets   8,101   8,101
Total current assets 263,234 236,831
Property, plant and equipment, net 47,760 47,972
Intangible assets, net of applicable amortization 123,420 129,160
Other assets   28,695   29,576
Total assets $ 463,109 $ 443,539
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current installments of other notes payable $ - $ 55
Current installments of other liabilities 74 514
Accounts payable 23,268 15,343
Deferred revenue 41 8,888
Accrued program costs 74,907 44,371
Accrued expenses and other payables 10,209 7,111
Income taxes payable   1,269  
Total current liabilities 109,768 76,282
Long-term debt and other notes payable, excluding current installments 44,488 68,321
Other liabilities, excluding current installments 3,036 3,054
Deferred income tax liabilities   27,556   27,556
Total liabilities   184,848   175,213
Commitments and contingent liabilities
Stockholders' Equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

Common stock, $.10 par value per share; authorized 40,000,000 shares;issued 31,807,223 shares at September 30, 2016 and 31,638,225 shares at December 31, 2015

3,182 3,164
Additional paid-in capital 70,458 68,534
Accumulated other comprehensive loss (4,429 ) (3,541 )
Retained earnings   217,135   208,507
286,346 276,664

Less treasury stock, at cost, 2,450,634 shares at September 30, 2016 and December 31, 2015

  (8,269 )   (8,269 )
American Vanguard Corporation stockholders’ equity 278,077 268,395
Non-controlling interest   184   (69 )
Total stockholders’ equity   278,261   268,326
Total liabilities and stockholders' equity $ 463,109 $ 443,539
 
       
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
For The Nine Months Ended September 30, 2016 and 2015
(Unaudited)
 
Increase (decrease) in cash 2016 2015
Cash flows from operating activities:
Net income $ 9,170 $ 3,400
Adjustments to reconcile net income to net cash provided by operating

activities:

Depreciation and amortization of fixed and intangible assets 12,367 12,190
Amortization of other long term assets 3,935 3,992
Amortization of discounted liabilities 28 118
Stock-based compensation 1,656 2,943
Tax benefit from exercise of stock options (82 ) (8 )
Operating loss from equity method investment 309 580
Changes in assets and liabilities associated with operations:
Increase in net receivables (19,202 ) (6,172 )
(Increase) decrease in inventories (5,201 ) 4,135
(Increase) decrease in prepaid expenses and other assets (1,011 ) 1,143
Decrease in income tax receivable/payable, net 1,519 4,739
Increase in accounts payable 7,925 3,010
Decrease in deferred revenue (8,847 ) (860 )
Increase in program payables 30,536 20,982
Increase in other payables and accrued expenses   3,098   1,615
Net cash provided by operating activities   36,200   51,807
Cash flows from investing activities:
Capital expenditures (6,122 ) (5,196 )
Investments (3,283 ) (125 )
Acquisitions of product lines and other intangible assets   (224 )   (36,435 )
Net cash used in investing activities   (9,629 )   (41,756 )
Cash flows from financing activities:
Net payments under line of credit agreement (24,000 ) (16,120 )
Increase in other notes payable 10,000
Payments on other long-term liabilities (541 ) (1,252 )
Tax benefit from exercise of stock options 82 8
Payment of cash dividends (289 ) (1,141 )

Net proceeds from the issuance of common stock (sale of stock under ESPP andexercise of stock options)

  204   254
Net cash used in financing activities   (24,544 )   (8,251 )
Net increase in cash and cash equivalents 2,027 1,800
Cash and cash equivalents at beginning of period 5,524 4,885
Effect of exchange rate changes on cash and cash equivalents  

(957

)   (1,256 )
Cash and cash equivalents at end of period $ 6,594 $ 5,429

Company:
American Vanguard Corporation
William A. Kuser, (949) 260-1200
Director of Investor Relations
[email protected]
or
Investor Representative
The Equity Group Inc.
www.theequitygroup.com
Lena Cati, (212) 836-9611
[email protected]

Source: American Vanguard Corporation



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Dividend, Vanguard, Earnings